Over the past two years, the outbreak of coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has centralized the interest of the health care systems and the scientific world. The majority of COVID-19-infected individuals recover fully. However, about 12–50% of patients experience various mid- and long-term effects after recovering from the initial illness. These mid- and long-term effects are collectively known as post-COVID-19 condition or 'long-COVID'. In the coming months, the long-term consequences of COVID-19 on the metabolic and endocrine systems may expect to rise and pose a global healthcare challenge. This review article discusses the possible metabolic and endocrine complications of long-COVID and the relevant research findings.

在过去两年中，由严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 引起的 2019 年冠状病毒病 (COVID-19) 爆发引起了医疗保健系统和科学界的关注。大多数感染 COVID-19 的人会完全康复。然而，大约 12-50% 的患者在从最初的疾病中恢复后会经历各种中长期影响。这些中长期影响统称为 COVID-19 后状况或“长期 COVID”。在接下来的几个月里，COVID-19 对代谢和内分泌系统的长期影响可能会加剧，并构成全球医疗保健挑战。这篇综述文章讨论了long-COVID可能的代谢和内分泌并发症以及相关研究结果。